India Pharma Outlook Team | Friday, 08 August 2025
German specialty glass maker Schott announced the expansion of syringe and cartridge glass tubing capabilities at its newly opened facility in Jambusar, Gujarat, and enhanced its pharmaceutical packaging portfolio. Schott now claims to be the largest producer of syringe and cartridge glass tubing in Asia.
The expansion is in direct response to growing demand for biologics, such as semaglutide (a GLP-1 receptor agonist for weight loss and Type 2 diabetes management). The GLP-1 sector that accounts for $6.8B is expected to grow at a CAGR of 33% alongside syringe and cartridge delivery formats becoming even more important.
Schott Glass India can now offer a comprehensive range of glass primary packaging solutions for pharma, from vials and ampoules to syringes and cartridges to support both domestic and global markets.
Also Read: Zydus Gets Health Canada Nod for ZDS-Varenicline Tablets
“We are proud to be the first in India to manufacture high-precision syringe and cartridge glass tubing locally. We are not only providing operational capabilities, but we are also enhancing India's healthcare self-sufficiency, aligned with the ‘Make in India’ vision and commitment to operational excellence and economic growth,” said Sundeep Prabhu, Senior Vice President – Sales & Marketing, Schott Glass India.
"Local manufacturing means a reliable and consistent supply chain for essential drug delivery systems. With our exact inner diameter control and the perfeXion quality system, which collects 100,000 data points per minute, we plan to manufacture with "zero defect," comments Pawan Kumar Shukla, President & Managing Director, Schott Glass India.
Founded in 1998, Schott Glass India operates the second largest pharmaceutical tubing plant in the company and a major producer of high-quality advanced drug delivery packaging solutions.
